200
Participants
Start Date
July 31, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Continuous glucose monitoring
Intravenous insulin therapy will be guided by interstitial glucose measurements using DexcomG7 continuous glucose monitor. Confirmatory blood glucose tests will be performed daily. In extreme clinical conditions (post-resuscitation, pH \< 7.20, severe hypoxia, severe haemodynamic compromise), confirmatory blood tests will be performed in 2 hour intervals until clinical improvement.
Control Arm - standard of care
Intravenous insulin dosing will be guided according to blood glucose measurements using RadiometerABL800 (standard of care). DexcomG7 continuous glucose monitor will be applied in blinded mode for interstitial glucose monitoring for later CGM metrics and comparison analysis.
University Medical Center Ljubljana, Ljubljana
University Medical Centre Ljubljana
OTHER